Conservative treatment of Peyronie's disease: a guide

World J Urol. 2024 May 13;42(1):317. doi: 10.1007/s00345-024-04975-6.

Abstract

Purpose: To review the literature on the topic, to suggest a common line of treatment applicable across a wide community of specialists, and to contribute in maintaining the high level of interest in this disease.

Methods: A comprehensive and exhaustive review of the literature was performed, identifying hundreds of articles on the topic.

Results: Peyronie's disease is a condition that has been recognized, studied, and treated for centuries; despite this, if one excludes surgery in cases in which the deformity is stable, no clear treatment (or line of treatment) is available for complete relief of signs and symptoms. Treatment options were divided into local, oral, and injection therapy, and a wide variety of drugs, remedies, and options were identified.

Conclusions: Low-intensity extracorporeal shock wave therapy, vacuum therapy, penile traction therapy, phosphodiesterase type 5 inhibitors, hyaluronic acid, and collagenase of Clostridium histolyticum may be recommended only in specific contexts. Further studies on individual options or potential combinations are required.

Keywords: Acute phase; Conservative treatment; Curvature; Medical treatment; Peyronie’s disease.

Publication types

  • Review

MeSH terms

  • Conservative Treatment* / methods
  • Extracorporeal Shockwave Therapy / methods
  • Humans
  • Hyaluronic Acid / administration & dosage
  • Hyaluronic Acid / therapeutic use
  • Male
  • Microbial Collagenase / administration & dosage
  • Microbial Collagenase / therapeutic use
  • Penile Induration* / therapy
  • Phosphodiesterase 5 Inhibitors / therapeutic use
  • Practice Guidelines as Topic
  • Traction / methods

Substances

  • Phosphodiesterase 5 Inhibitors
  • Hyaluronic Acid
  • Microbial Collagenase